UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metallization of TiO2(110) with Gold and Lithium

Journal of physical chemistry. C, 2021-12, Vol.125 (48), p.26744-26754

2021

Volltextzugriff (PDF)

Effect of Adsorption on the Photoluminescence of Zinc Oxide Nanoparticles

Journal of physical chemistry. C, 2018-08, Vol.122 (33), p.18982-18994

2018

Volltextzugriff (PDF)

Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

European heart journal, 2014-09, Vol.35 (33), p.2249-2259

2014

Volltextzugriff (PDF)

Efficacy and safety of evolocumab in patients on high- vs moderate-intensity background statin therapy

Atherosclerosis, 2016-09, Vol.252, p.e230-e231

2016

Volltextzugriff (PDF)

Pharmaceutical interventions for obesity: a public health perspective

Diabetes, obesity & metabolism, 2011-06, Vol.13 (6), p.490-497

2011

Volltextzugriff (PDF)

Impact of target-mediated elimination on evolocumab dose and regimen

Atherosclerosis, 2015-07, Vol.241 (1), p.e197-e197

2015

Volltextzugriff (PDF)

Elucidating the mechanism for PCSK9 inhibition-mediated reduction in LP(A)

Atherosclerosis, 2015-07, Vol.241 (1), p.e67-e67

2015

Volltextzugriff (PDF)

Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

VALUE IN HEALTH, 2016, Vol.19 (3), p.A3-A3

2016

Volltextzugriff (PDF)

Metallization of TiO 2 (110) with Gold and Lithium

Journal of physical chemistry. C, 2021-12, Vol.125 (48), p.26744-26754

2021

Volltextzugriff (PDF)

FREQUENCY OF STATIN DOWNTITRATION DURING OPEN LABEL EVOLOCUMAB TREATMENT IN THE OSLER-2 STUDIES

Canadian journal of cardiology, 2016, Vol.32 (10), p.S122-S122

2016

Volltextzugriff (PDF)

Safety, Tolerability, and Efficacy of Long-Term Administration of Amg 145: Preliminary Results From the Osler Study

Canadian journal of cardiology, 2013-10, Vol.29 (10), p.S332-S332

2013

Volltextzugriff (PDF)

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Clinical cardiology (Mahwah, N.J.), 2016-06, Vol.39 (6), p.313-320

2016

Volltextzugriff (PDF)

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

JAMA cardiology, 2017-10, Vol.2 (10), p.1069

2017

Volltextzugriff (PDF)

P2989Is lipoprotein(a) metabolism linked to the transport and catabolic rates of apolipoprotein B-100 containing lipoproteins?

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

P2991Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

3105Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolaemia: the Trial Assessing long-term Use of PCSK9 inhibition in Subjects with Genetic LDL disorders (TAUSSIG)

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial

Atherosclerosis, 2018-08, Vol.275, p.e9-e10

2018

Volltextzugriff (PDF)

FREQUENCY OF STATIN DOWNTITRATION DURING OPEN LABEL EVOLOCUMAB TREATMENT IN THE OSLER-2 STUDIES

Canadian journal of cardiology, 2016-10, Vol.32 (10), p.S122-S122

2016

Volltextzugriff (PDF)

P4439Adherence to intensive medical management in the year following hospitalization for myocardial infarction

European heart journal, 2017-08, Vol.38 (suppl_1)

2017

Volltextzugriff (PDF)

Surface Segregation of Zinc Oxide Nanoparticles in Polymer Films and Fibers: Implications for Functionalized Fabrics

ACS applied nano materials, 2022-03, Vol.5 (3), p.3992-3999

2022

Volltextzugriff (PDF)

CV4 - Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

Value in health, 2016-05, Vol.19 (3), p.A3-A3

2016

Volltextzugriff (PDF)

Exploring the user experiences of collaborative online learning

2015 Fifteenth International Conference on Advances in ICT for Emerging Regions (ICTer), 2015, p.268-268

Somaratne, R. M. P. N.

2015

Volltextzugriff (PDF)

Statin therapy is a major determinant of PCSK9 plasma concentration: data from four clinical trials with AMG 145

European heart journal, 2013-08, Vol.34 (suppl 1), p.P681-P681

2013

Volltextzugriff (PDF)

Effect of polishing on glycemic index and antioxidant properties of red and white basmati rice

Food chemistry, 2017-12, Vol.237, p.716-723

2017

Volltextzugriff (PDF)

Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design

The American heart journal, 2021-01, Vol.231, p.96-104

2021

Volltextzugriff (PDF)

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(111)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(130)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(48)
Humans
(31)
Cardiovascular
(26)
Male
(23)
Cardiovascular System & Cardiology
(21)
Middle Aged
(21)
Cardiac & Cardiovascular Systems
(20)
Female
(20)
Aged
(16)
Risk Factors
(12)
Treatment Outcome
(11)
Cholesterol, Ldl - Blood
(9)
General & Internal Medicine
(9)
Medicine, General & Internal
(9)
Adult
(8)
Antibodies, Monoclonal - Therapeutic Use
(8)
Biological And Medical Sciences
(8)
Cholesterol
(8)
Medical Sciences
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metallization of TiO2(110) with Gold and Lithium

Effect of Adsorption on the Photoluminescence of Zinc Oxide Nanoparticles

Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials

Efficacy and safety of evolocumab in patients on high- vs moderate-intensity background statin therapy

Pharmaceutical interventions for obesity: a public health perspective

Impact of target-mediated elimination on evolocumab dose and regimen

Elucidating the mechanism for PCSK9 inhibition-mediated reduction in LP(A)

Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

Metallization of TiO 2 (110) with Gold and Lithium

FREQUENCY OF STATIN DOWNTITRATION DURING OPEN LABEL EVOLOCUMAB TREATMENT IN THE OSLER-2 STUDIES

Safety, Tolerability, and Efficacy of Long-Term Administration of Amg 145: Preliminary Results From the Osler Study

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States

Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease

P2989Is lipoprotein(a) metabolism linked to the transport and catabolic rates of apolipoprotein B-100 containing lipoproteins?

P2991Evolocumab lowers plasma Lp(a) concentration by two kinetic modes of action: From the FLOREY Study

3105Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolaemia: the Trial Assessing long-term Use of PCSK9 inhibition in Subjects with Genetic LDL disorders (TAUSSIG)

Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial

FREQUENCY OF STATIN DOWNTITRATION DURING OPEN LABEL EVOLOCUMAB TREATMENT IN THE OSLER-2 STUDIES

P4439Adherence to intensive medical management in the year following hospitalization for myocardial infarction

Surface Segregation of Zinc Oxide Nanoparticles in Polymer Films and Fibers: Implications for Functionalized Fabrics

CV4 - Cost-Effectiveness of LDL-C Lowering With Evolocumab In Patients With High Cardiovascular Risk In The United States

Exploring the user experiences of collaborative online learning

Statin therapy is a major determinant of PCSK9 plasma concentration: data from four clinical trials with AMG 145

Effect of polishing on glycemic index and antioxidant properties of red and white basmati rice

Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT): Rationale and design

Suchergebnisse filtern